"Get daily stock ideas top-performing Wall Street analysts.
Get short term trading ideas from the MarketBeat Idea Engine. AIStockFinder will not accept liability for any loss or damage, including without limitation to, any loss of profit, which may arise directly or indirectly from use of or reliance on such information.Homology Medicines, Inc. FIXX was a big mover last session, as the company saw its shares rise more than 8% on the day. BofA Merrill Lynch, Cowen and Evercore ISI served as the underwriters for the IPO and BTIG was co-manager.In the past three months, Homology Medicines insiders have not sold or bought any company stock.Homology Medicines does not have a long track record of dividend growth.Learn everything you need to know about successful options trading with this three-part video course.Earnings for Homology Medicines are expected to grow in the coming year, from ($3.05) to ($2.91) per share.Homology Medicines' mailing address is ONE PATRIOTS PARK, BEDFORD MA, 01730. Find real-time FIXX - Homology Medicines Inc stock quotes, company profile, news and forecasts from CNN Business. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist.Looking for new stock ideas? Learn about financial terms, types of investments, trading strategies and more.View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks.
Get short term trading ideas from the MarketBeat Idea Engine. (FIXX) raised $100 million in an initial public offering (IPO) on Wednesday, March 28th 2018. The average price target represents a 118.95% increase from the last price of $15.30. The company earns $-103,920,000.00 in net income (profit) each year or ($2.47) on an earnings per share basis. In the short term (2weeks), FIXX's stock price should underperform the market by -3.04%.During that period the price should oscillate between -11.89% and +10.42%.. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN.
Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Please log in to your account or sign up in order to add this asset to your watchlist.Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:Get daily stock ideas top-performing Wall Street analysts. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.You have already added five stocks to your watchlist.
Homology Medicines employs 124 workers across the globe.Shares of FIXX can be purchased through any online brokerage account. Mr. Poulton ...At the moment the company generates 2M USD in revenues.On its last earning announcement, the company reported a loss of -2.47$ per share.There is no announcement at the moment.BEDFORD, Mass., July 21, 2020 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Jeff Poulton has been appointed to the Board of Directors.© AIStockFinder 2018.
Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value.
Executive with Extensive Rare Disease Expertise in Global Finance and Commercial Operations - BEDFORD, Mass., July 21, 2020 ...The book value per share is 6.05$Homology Medicines, Inc. operates as a genetic medicines company. Homology Medicines is scheduled to release their next quarterly earnings announcement on Monday, May 13th 2019.
View the latest Homology Medicines Inc. (FIXX) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Get international weather forecasts with this highly customizable extension
Homology Medicines Stock Price Forecast, FIXX stock price prediction.
Find the latest Homology Medicines, Inc. (FIXX) stock quote, history, news and other vital information to help you with your stock trading and investing. Homology Medicines last issued its earnings results on May 7th, 2020.
It develops genetic medicines by translating proprietary, next generation gene editing and gene therapy technologies into novel treatments for patients with rare diseases. All Rights Reserved.Any opinions, news, research, analyses, prices, or other information offered by AIStockFinder is provided as general market commentary, and does not constitute investment advice.
View Earnings Estimates for Homology Medicines. Find the latest analyst research for Homology Medicines, Inc. Common Stock (FIXX) at Nasdaq.com. Find real-time SFIX - Stitch Fix Inc stock quotes, company profile, news and forecasts from CNN Business. High Growth Earnings: FIXX is forecast to remain unprofitable over the next 3 years.
What this means: Homology Medicines Inc (FIXX) gets an Overall Rank of 58, which is an above average rank under InvestorsObserver's stock ranking system.
FIXX Stock Analysis Overview .